Feng Huang Yi

Gallus gallus domesticus Linnaeus

Also known as: Inner Shell of(English) 凤凰衣(Chinese)

Fêng Huang I

Updated October 23, 2026 · Not yet clinically reviewed

Feng Huang Yi
AI illustration, not for identification

Safety at a glance

Caution

2 recorded drug interactions, 1 major or contraindicated

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
transforming phlegm
Temperature
Warm
Taste
Sweet
Channels
Lung

Functions

Nourishes Yin and cleanses the Lungs

Traditional uses

Feng Huang Yi is the thin inner membrane of the hen's eggshell (Gallus gallus domesticus; Membrana Follicularis Ovi), a sweet substance entering the Lung channel. It nourishes Yin and clears the Lungs, moistening dryness of the respiratory tract, and is used chiefly for chronic and lingering dry cough and for Lung Yin deficiency with a dry, scratchy throat. A characteristic traditional application is hoarseness and loss of voice (aphonia), where it soothes and moistens the throat.

It is also applied to scrofula and, topically, to non-healing sores and ulcers, the powder being sprinkled on the affected area. Internally it is decocted at about 3-9 g or taken as powder. A gentle, food-grade animal substance, it is typically used as an adjunct within moistening, Yin-nourishing formulas under professional guidance.

Formulas using this herb

Botanical

Feng Huang Yi (凤凰衣) is most commonly recorded in Chinese materia medica not as a plant at all but as the thin inner membrane of the hen's eggshell (the chorioallantoic membrane peeled from the inside of a chicken egg after the contents are removed), used as a folk remedy for chronic cough and to promote healing of ulcerations. Some regional sources apply the same name to flower-bract structures of certain ornamental plants, but without a corroborating Latin name the identification cannot be made with confidence. Because the substance is most likely an animal-derived material rather than a plant — and possibly not in standard pharmacopoeial use — the record follows the unidentifiable/non-plant null-pattern.

Family
Phasianidae
Pharmaceutical name
Membrana Follicularis Ovi

Constituents

Type I collagen

Fibrillar structural protein (collagen) · The dominant protein of the membrane; the fibre network is predominantly type I collagen with types V and X also reported

Forms the interwoven fibre scaffold that gives the membrane its structure. Its hydroxyproline-rich composition is what distinguishes the shell membranes from the organic matter of the shell itself in amino acid analysis, and it is the basis of the material's use as a wound and ulcer dressing.

Type X collagen

Network-forming (non-fibrillar) collagen · Present in significant quantity alongside type I

A short-chain network collagen normally associated with hypertrophic cartilage. Its presence is part of the rationale for testing eggshell membrane in joint and connective tissue disorders.

Glycosaminoglycans (hyaluronic acid and a chondroitin sulfate-dermatan sulfate copolymer)

Glycosaminoglycan · Two glycosaminoglycans are documented in the membrane; uronic acid, their structural marker, occurs at similar levels in inner and outer shell membranes and about fivefold lower than in the organic matter of the shell

These are the constituents that the joint-health supplement literature is built around, being the same classes used as standalone osteoarthritis supplements. In the membrane they are present as native, unstandardised amounts, not as a measured dose.

Sialic acid (N-acetylneuraminic acid)

Amino sugar (nonulosonic acid) · Higher in the inner shell membrane than the outer, and highest of all in the organic matter of the shell

A terminal sugar on the membrane glycoproteins. Its uneven distribution between inner membrane, outer membrane and shell organic matter means that how carefully the membrane is separated from adherent shell changes the composition of the finished drug.

Desmosine and isodesmosine

Crosslinking amino acids (tetrafunctional lysine-derived) · About 28 micrograms per 100 mg dry weight of membrane

These crosslinks give the membrane its elastic, tear-resistant character. They are constituents of the shell membrane protein itself and do not indicate contamination with elastin, which was established by specific enzymatic and chemical hydrolysis.

Ovalbumin, ovotransferrin and lysozyme

Egg white proteins (major egg allergens) · Inherent and abundant residues of egg white carried on the membrane; not removed by ordinary drying

These are the clinically important constituents of Feng Huang Yi, because they are the named major egg allergens: ovalbumin is Gal d 2, ovotransferrin is Gal d 3 and lysozyme is Gal d 4. Proteomic work on eggshell membrane identifies them directly, along with ovoinhibitor, ovostatin and ovalbumin-related protein X. Their presence means the drug is an egg product for allergy purposes, whatever the preparation.

Cystine-rich shell membrane proteins

Disulfide-crosslinked structural protein · Cystine is a prominent component of the membrane amino acid profile

The disulfide crosslinking makes the membrane poorly soluble and resistant to digestion, which is why commercial preparations are hydrolysed enzymatically or with subcritical water rather than used whole.

Drug interactions

Any therapy in a patient with egg allergy, including egg-cultured vaccines and egg-derived lysozyme preparations

Major · Potentially life-threatening in the sensitised patient — anaphylaxis risk · Evidence level: Probable

Feng Huang Yi is the membrane lining a chicken eggshell, and proteomic analysis of eggshell membrane identifies ovalbumin, ovotransferrin and lysozyme among its proteins — these are Gal d 2, Gal d 3 and Gal d 4, three of the four principal egg white allergens, and together they account for the large majority of egg white allergenic protein. The drug is therefore an egg protein exposure. There is no published assay of residual allergen in medicinal eggshell membrane to say how much survives decoction, so the exposure cannot be quantified, but absence of an assay is not evidence of absence. In a patient already sensitised, this adds an allergen source alongside any other egg-derived exposure they are managing.

Clinical note: Contraindicated in known egg allergy. Ask about egg allergy before prescribing, including in children, and record the herb as an egg-containing product so that it is visible to other clinicians assessing an allergic reaction. If a patient on Feng Huang Yi develops urticaria, angioedema, wheeze or gastrointestinal symptoms, stop it and treat as an egg reaction.

Glucosamine and chondroitin sulfate joint supplements

Minor · Low — duplication rather than hazard · Evidence level: Theoretical

Eggshell membrane contains hyaluronic acid and a chondroitin sulfate-dermatan sulfate copolymer natively, and the commercial supplements built on it are marketed for the same indication as glucosamine and chondroitin. Taking both duplicates the same class of material at an unmeasured combined dose. No adverse interaction has been reported; the concern is cost and unmonitored intake rather than toxicity.

Clinical note: No action beyond noting the duplication. Do not treat the TCM decoction as interchangeable with a standardised eggshell membrane supplement — the doses and preparations are not comparable.

Dosage

FormAmountFrequencyNotes
decoction3–9 gDaily
Standard oral dose per Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 377–379. Exact wording: Normally, 3–9 g is decocted with water as an oral

Dui yao: classical pairings

Feng Huang Yi + Chan Tui蝉蜕

Disperses wind-heat and benefits the throat while nourishing and restoring the voice, for hoarseness and loss of voice.

Named pairing — Lü Jingshan, Shi Jinmo Dui Yao

Evidence

Study design on record, not certainty of outcome.

Randomized controlled trial
2
Other clinical trial
1

Eggshell membrane in the treatment of pain and stiffness from osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled clinical study

Ruff, Kevin J.; Winkler, Anne; Jackson, Robert W.; DeVore, Dale P.; Ritz, Barry W. · Clinical Rheumatology · 2009 · RCT

Randomized controlled trial · Verified

Sixty-seven patients with knee osteoarthritis randomised to 500 mg/day of a proprietary Natural Eggshell Membrane preparation or placebo for eight weeks, with WOMAC pain and stiffness as the primary endpoint. This is the strongest human evidence for the material, but two qualifications matter for a TCM reference: the indication tested is knee osteoarthritis, not the Lung and Yin-nourishing indications Feng Huang Yi is prescribed for, and the corresponding author is affiliated with ESM Technologies LLC, the manufacturer of the tested product.

doi:10.1007/s10067-009-1173-4

A Randomized, Double-Blind, Placebo-Controlled, Prospective Clinical Trial Evaluating Water-Soluble Chicken Eggshell Membrane for Improvement in Joint Health in Adults with Knee Osteoarthritis

Hewlings, Susan; Kalman, Douglas; Schneider, Luke V. · Journal of Medicinal Food · 2019 · RCT

Randomized controlled trial · Verified

Eighty-eight adults with knee osteoarthritis randomised to 450 mg/day of a water-soluble chicken eggshell membrane hydrolysate or placebo for 12 weeks. The honest reading is negative on the pre-specified analysis: without normalisation, no statistically significant improvement was seen in WOMAC, six-minute walk test or range of motion, and the positive findings the paper reports come from a normalised improvement-over-baseline analysis. The product was safe. Two authors received funding from the sponsor and a third is a paid consultant to it.

doi:10.1089/jmf.2019.0068

Eggshell membrane: A possible new natural therapeutic for joint and connective tissue disorders. Results from two open-label human clinical studies

Ruff, Kevin J.; DeVore, Dale P.; Leu, Michael D.; Robinson, Mark A. · Clinical Interventions in Aging · 2009 · cohort

Other clinical trial · Verified

Two small single-centre open-label studies, 11 and 28 patients, given 500 mg/day of Natural Eggshell Membrane for four weeks, reporting reductions in joint pain and gains in flexibility with no adverse events. Uncontrolled and unblinded, so the effect sizes cannot be separated from placebo and regression to the mean; the useful content is the tolerability signal. The corresponding author is employed by the product manufacturer.

doi:10.2147/cia.s5797

Safety

Contraindications

It is not suitable for patients with weakness of the spleen and stomach complicated by dampness stagnation.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 377–379.

Cultural and historical

Ming Yi Bie Lu (Miscellaneous Records of Famous Physicians), entered as luan zhong bai pi, the white skin within the egg · attributed to Tao Hongjing, c. 500 CE

Earliest listing of the drug, recorded as treating long-standing cough with binding — the chronic cough and loss of voice indication it still carries. The later name Feng Huang Yi, phoenix robe, is a decorative renaming of the same material.

Bi Xiao Fang (Formulas of Certain Efficacy), Meng Shen, cited under the name ji zi bai pi · Tang dynasty, 7th-8th century

Records the membrane under the name chicken egg white skin, one of the earliest of the several alternative names the drug accumulated.

Ben Cao Meng Quan (Enlightenment of Materia Medica), Chen Jiamo · Ming dynasty, 1565

Records the drug under the name feng huang tui, phoenix moult — the name from which the modern Feng Huang Yi derives.

References

  1. Nakano, T; Ikawa, N I; Ozimek, L. Chemical composition of chicken eggshell and shell membranes. Poultry Science. 2003 doi:10.1093/ps/82.3.510
  2. Ahlborn, G. J.; Clare, D. A.; Sheldon, B. W.; Kelly, R. W.. Identification of Eggshell Membrane Proteins and Purification of Ovotransferrin and β-NAGase from Hen Egg White. The Protein Journal. 2006 doi:10.1007/s10930-006-0010-8
  3. Leach, R. M.; Rucker, R. B.; Van Dyke, G. P.. Egg shell membrane protein: A nonelastin desmosine/ isodesmosine-containing protein. Archives of Biochemistry and Biophysics. 1981 doi:10.1016/0003-9861(81)90042-4
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice